TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
BETHLEHEM, Pa., May 31, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2017 Global Healthcare Conference in New York, New York. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on June 7, 2017, at approximately 8:30 AM Eastern Time (5:30 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: http://wsw.com/webcast/jeff105/osur.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. For more information on OraSure Technologies, please visit www.orasure.com.
Company contact: Ronald H. Spair Chief Financial Officer 610-882-1820 [email protected] www.orasure.com Shauna White Corporate Marketing Manager 484-353-1575 [email protected] www.orasure.com
